Skip to main content

Dermatomyositis, Skin

  • Reference work entry
  • First Online:
Encyclopedia of Medical Immunology

Synonyms

Amyopathic dermatomyositis; Dermatomyositis sine myositis; Idiopathic inflammatory myopathy

Definition

Dermatomyositis is a progressive connective tissue disorder characterized by inflammatory and degenerative changes of the muscles and skin.

Clinical Presentation

The cutaneous manifestations of dermatomyositis are arguably the most distinct and dramatic of any other autoimmune connective tissue disease. Once recognized, the clinician may establish the diagnosis even when there is histologic as well as serologic ambiguity. The unique quality of the rash is as important as its typical location pattern. Lesions typically present as patches or plaques, and all are characterized by either pink or violaceous erythema that can be with or without scale. The heliotrope eruption of the eyelids, as is typical for most of the cutaneous findings in dermatomyositis, is very distinctive and may be associated with persistent periocular edema. However, it may initially be thought to be...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 799.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Antiga E, Kretz CC, Klembt R, et al. Characterization of regulatory T cells in patients with dermatomyositis. J Autoimmun. 2010;35(4):342–50.

    PubMed  CAS  Google Scholar 

  • Burd CJ, Kinyamu HK, Miller FW, Archer TK. UV radiation regulates Mi-2 through protein translation and stability. J Biol Chem. 2008;283(50):34976–82.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Caproni M, Torchia D, Cardinali C, et al. Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol. 2004;151(4):784–91.

    PubMed  CAS  Google Scholar 

  • Chaisson NF, Paik J, Orbai AM, et al. A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature. Medicine. 2012;91(4):220–8.

    PubMed  PubMed Central  Google Scholar 

  • Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol. 1996;27(1):15–9.

    PubMed  CAS  Google Scholar 

  • Dawn A, Thevarajah S, Cayce KA, et al. Cutaneous blood flow in dermatomyositis and its association with disease severity. Skin Res Technol. 2007;13(3):285–92.

    PubMed  Google Scholar 

  • Dourmishev LA, Wollina U. Dermatomyositis: immunopathologic study of skin lesions. Acta Dermatovenerol Alp Panonica Adriat. 2006;15(1):45–51.

    Google Scholar 

  • Dourmishev L, Meffert H, Piazena H. Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects. Photodermatol Photoimmunol Photomed. 2004;20(5):230–4.

    PubMed  CAS  Google Scholar 

  • Fiorentino D, Chung L, Zwerner J, et al. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011;65(1):25–34.

    PubMed  PubMed Central  Google Scholar 

  • Grassi M, Capello F, Bertolino L, et al. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis. Clin Exp Dermatol. 2009;34(8):910–4.

    PubMed  CAS  Google Scholar 

  • Hausmann G, Mascaro Jr JM, Herrero C, et al. Cell adhesion molecule expression in cutaneous lesions of dermatomyositis. Acta Derm Venereol. 1996;76(3):222–5.

    PubMed  CAS  Google Scholar 

  • Kashiwagi M, Morgan BA, Georgopoulos K. The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny. Development. 2007;134(8):1571–82.

    PubMed  CAS  Google Scholar 

  • Kim JS, Werth VP. Identification of specific chondroitin sulfate species in cutaneous autoimmune disease. J Histochem Cytochem. 2011;59(8):780–90.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Kim JS, Bashir MM, Werth VP. Gottron’s Papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature. J Invest Dermatol. 2012;132(7):1825–32.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Love LA, Weinberg CR, McConnaughey DR, et al. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum. 2009;60(8):2499–504.

    PubMed  PubMed Central  Google Scholar 

  • Magro CM, Crowson AN. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol. 1997;24(9):543–52.

    PubMed  CAS  Google Scholar 

  • Magro CM, Segal JP, Crowson AN, Chadwick P. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis. J Cutan Pathol. 2010;37(6):659–71.

    PubMed  Google Scholar 

  • Mascaro Jr JM, Hausmann G, Herrero C, et al. Membrane attack complex deposits in cutaneous lesions of dermatomyositis. Arch Dermatol. 1995;131(12):1386–92.

    PubMed  Google Scholar 

  • McNiff JM, Kaplan DH. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus. J Cutan Pathol. 2008;35(5):452–6.

    PubMed  Google Scholar 

  • Ogata A, Endo M, Aoi J, et al. The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis. Biochem Biophys Res Commun. 2012;418(3):494–9.

    PubMed  CAS  Google Scholar 

  • Okada S, Weatherhead E, Targoff IN, et al. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum. 2003;48(8):2285–93.

    PubMed  Google Scholar 

  • Pablos JL, Santiago B, Galindo M, et al. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis. J Pathol. 1999;188(1):63–8.

    PubMed  CAS  Google Scholar 

  • Robinson AB, Reed AM. Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol. 2011;7(11):664–75.

    PubMed  CAS  Google Scholar 

  • Shrestha S, Wershil B, Sarwark JF, et al. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum. 2010;62(9):2813–22.

    PubMed  PubMed Central  Google Scholar 

  • Smith ES, Hallman JR, DeLuca AM, et al. Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol. 2009;31(1):61–7.

    PubMed  Google Scholar 

  • Solomon GJ, Magro CM. Foxp3 expression in cutaneous T-cell lymphocytic infiltrates. J Cutan Pathol. 2008;35(11):1032–9.

    PubMed  Google Scholar 

  • Torchia D, Caproni M, Volpi W, et al. The Fas/Fas ligand system, rather than granzyme B, may represent the main mediator of epidermal apoptosis in dermatomyositis. Clin Exp Dermatol. 2010;35(6):669–70.

    PubMed  CAS  Google Scholar 

  • Wenzel J, Tuting T. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in “interface dermatitis”. J Invest Dermatol. 2008;128(10):2392–402.

    PubMed  CAS  Google Scholar 

  • Wenzel J, Scheler M, Bieber T, Tuting T. Evidence for a role of type I interferons in the pathogenesis of dermatomyositis. Br J Dermatol. 2005;153(2):462–3; author reply 3–4.

    PubMed  CAS  Google Scholar 

  • Wenzel J, Schmidt R, Proelss J, et al. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol. 2006;31(4):576–82.

    PubMed  CAS  Google Scholar 

  • Wong D, Kea B, Pesich R, et al. Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases. PLoS One. 2012;7(1):e29161.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Zahn S, Barchet W, Rehkamper C, et al. Enhanced skin expression of melanoma differentiation-associated gene 5 (MDA5) in dermatomyositis and related autoimmune diseases. J Am Acad Dermatol. 2011;64(5):988–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Fiorentino .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

Fiorentino, D., Franks, A.G. (2014). Dermatomyositis, Skin. In: Mackay, I.R., Rose, N.R., Diamond, B., Davidson, A. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84828-0_278

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-84828-0_278

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-84827-3

  • Online ISBN: 978-0-387-84828-0

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics